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Summary.-The importance of the contaminant OTS in the promoting activity of
commercial saccharin on rat bladder neoplasia was investigated. OTS, OTS-free
and OTS-contaminated saccharin were administered in the drinking water or diet
for 2 years to groups of rats pretreated with an intravesical instillation of MNU; OTS
alone and OTS-free saccharin were also given to groups of rats not pretreated with
MNU.
Administration of OTS was not associated with changes in urinary pH, crystalluria
or calculus formation, had no effect on the histology of normal rat bladder, and did
not increase the incidence of bladder hyperplasia or neoplasia elicited by pretreat-
ment with MNU. No differences could be found between the effect of OTS-free or
OTS-contaminated saccharin on bladders of rats pretreated with MNU. These
results indicate that OTS contamination played no part in the reported promoting
activity of saccharin on the rat bladder.
Administration of saccharin did not increase urinary pH, crystalluria or calculus
formation, and failed to promote bladder neoplasia after a carcinogenic dose of MNU,
though the numbers of proliferative lesions in the bladder were increased.
DURING THE last 10 years, saccharin has
been tested for carcinogenicity in rats,
mice, hamsters and monkeys. Until re-
cently (Arnold et al., 1977b) single-
generation feeding studies have failed to
demonstrate an unequivocal carcinogenic
effect of saccharin in any of these species
(Lessel, 1971; Schmahl, 1973; Munro et al.,
1.975; Kroes et al., 1977; Chowaniec &
Hicks, 1979). However, in 2-generation
feeding studies, saccharin was found to
induce bladder neoplasms in F1 male rats
when fed at levels of 500 or 7.50% in the
diet (Taylor & Friedman, 1974; Tisdel
et al., 1974; Arnold et al., 1977b). Further-
more, the administration of saccharin
either in the drinking water (2 g/kg/day)
or diet (4 g/kg/day) to rats previously
given a single sub-carcinogenic dose of
N-methyl-N-nitrosourea (MNU) produced
a high incidence ofbladder tumours (Hicks
et al., 1973a, 1975, 1978; Hicks &
Chowaniec, 1977; Hicks et al., 1978). These
findings suggested that saccharin could
promote carcinogenesis initiated by MNU,
and recent work by Cohen et al. (1979)
confirmed a promoting effect of saccharin
on bladder neoplasia after a threshold dose
of N(4-(5-nitro-2-furyl)-2-thiazolyl) form-
amide (FANFT).
A variety of impurities are present in
commercial saccharin, the best known
being ortho-toluene sulphonamide (OTS);
this impurity has been detected at levels
as high as 5000 pts/106 in saccharin manu-
factured by the Remsen-Fahlberg pro-
cess, and has also been found, in much
smaller amounts, in some batches of
saccharin produced by the Maumee pro-
cess. In the study by Hicks and her
colleagues OTS was present at a concen-
tration of 810 pts/106 (Hicks et al., 1973b).
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OTS is known to inhibit carbonic an-
hydrase (Kinzer, 1973) which could in-
crease urinary pH, and favour the forma-
tion of urinary calculi. The possibility
therefore arose that operation of such
factors might have played a role in the
carcinogenicity or promoting activity of
saccharin.
The aim ofthe present experiments was
therefore to examine the importance of
OTS in carcinogenicity studies with
saccharin, by comparing the incidence of
neoplasia in MNU-pretreated bladders
after long term administration of OTS-
free saccharin, OTS-contaminated sac-
charin and OTS alone. OTS was also
tested in rats not pretreated with MNU.
The original experiments by Hicks and
her co-workers used drinking water as the
vehicle for saccharin administration, and
the same vehicle was used in the main
experiment of the current investigations
(Exp. 1). However, some groups of rats
developed signs of severe dehydration, so
a second smaller experiment was set up in
which compounds were administered in
the diet (Exp. 2).
MATERIALS AND METHODS
Materials. MNU was synthesized at the
Courtauld Institute of Biochemistry, AMiddle-
sex Hospital Medical School, and checked
for purity by melting-point determination
and spectrophotometric analysis. Separate
samples were used for Exps 1 and 2.
Sodium saccharin, manufactured by the
Maumee process and free from OTS con-
tamination, was supplied by Sherwin Williams
Chemicals, Cleveland, Ohio.
Sodium saccharin, manufactured by the
Remson Fahlberg process and containing
40 pts/106 OTS, was obtained from The Boots
Co. Ltd, Nottingham.
OTS was supplied by Monsanto Industrial
Chemicals Co., St Louis, Missouri. The sample
was found to have 1 peak on GLC analysis.
Animals and diet. Female Wistar SPF
weanling rats, free from the bladder parasite
Trichosomoides crassicauda, were supplied by
Oxfordshire Laboratory Animal Colonies,
Bicester, Oxfordshire. Rats were housed in
rooms maintained at 20 + 1°C, with a relative
humidity of 50-60%. Basic diet was Spratt's
Laboratorv Animal Diet No. 2 and drinking
water was taken from the mains supply;
1oth were available ad libitun.
Experimental design.-In Exp. 1, rats were
TABLE I. Experimental design
No. of
rats
Group at start
Pre-
treatment *
MNU
MNU
AINU
Treatment
Exp. 1
OTS-free
saccharin
OTS
I\INU OTS-contaminated
saccharin
MINU OTS
OTS
Exp. 2
OTS-free
saccharin
AINU OTS
OTS
Desired
daily
intake
2 g/kg
0-08 mg/kg
2 g/kg
0.1%
0.1%
2 g/kg
Actual
daily
intake
2-83 g/kgt
0 13mg/lkgt
3-25 g/kgt
0.Io
(70 mg/kg)t
Vehicle
Drinking
water
Drinking
water
Drinking
water
Drinking
water
0-1 0°0 Drinking
(70 mg/kg)t water
1-74 g/kgt Diet
70 mg/kg 79 mg/kgt Diet
70 mg/kg 79 mg/kgt Diet
* 0-15 ml of a solution containing 10 mg/ml MNU, instilled intravesicularly.
t Figures represent the mean daily intake of saccharin or OTS for each group of rats over a 2yr period,
calculated from monthly data on water or food consumption, and body weight.
A
B
C
D
E
63
63
63
6.3
63
F 63
G 63
H
I
J
50
50
50
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randomly distributed into 7 groups (A-G)each
of 63 animals, and housed 7 to a cage (Table
I). Groups A-E were instilled intravesically
via urethral catheter with 0-15 ml of a freshly
prepared saturated solution of MNU in
090o NaCl (- 10 mg MNU/ml). The proce-
dure was performed under barbiturate anaes-
thesia. Two weeks later, all groups were
administered the appropriate chemicals in
the drinking water. Group A received no
chemicals, and served as the MNU-treated
control. OTS-free (Group B) or OTS-con-
taminated (Group D) saccharin was added to
drinking water to provide a desired daily
intake of 2 g/kg. In practice, the concentra-
tion of saccharin in the drinking water was
varied between 1-330' and208% in anattempt
to provide the required intake. Group C was
administered OTS at a desired level of 0-08
mg/kg/day, the intake equivalent to the
amount ofOTS in the contaminated saccharin
(40 pts/106). Groups E and G were given OTS
at the level of maximum solubility in tap
water (001%) which provided a daily intake
of 70 mg/kg. Group F served as untreated
controls. Administration of chemicals con-
tinued for 2 years.
Sixteen months after the start of Exp. 1,
a supplementary study was initiated (Exp.
2). This consisted of 3 groups (H-J) each of
50 rats, housed 5 to a cage. The bladders of
Group I rats were instilled with MNU as
previously described. Eight days later, the
groups were administered the appropriate
chemicals in the diet. Group H received
OTS-free saccharin at a desired level of 2
g/kg/day. To achieve this intake the concent-
ration of saccharin in the diet was varied
between 2 and 3-500 during the experiment.
Groups I and J were fed OTS at a desired
level of 70 mg/kg/day, providing a similar
OTS intake to that in Groups E and G in Exp.
1. Administration of chemicals continued for
2 years.
Measurements. Rats were observed daily
for signs ofill health. Rats that became ill and
whose condition did not improve were killed
and subjected to a post mortem examination.
Animals were wreighed individually at weekly
intervals; food and water consumptions were
measured twice w-eekly, that is, over a 3-day
and a subsequent 4-day period for each cage of
rats. Adjustments to the concentration of the
chemical in the drinking water or the diet
were made, oIn the basis of body weight
change and water and food consumptions, to
maintain the correct dosage as far as possible.
Three renal-function tests were carried out
on the same 8-10 rats from each group at
6-week intervals. To measure renal diluting
capacity, rats were given a water load of
25 ml/kg, and urine collected over the next
2 h. The specific gravity and volume of the
sample were measured, and a cell count
performed. To measure renal concentrating
ability, urine was collected for 6 h from rats
housed without water. Samples were exam-
ined by Bili-Labstix (Ames Company, Stoke
Poges, Slough) for their content of albumin,
glucose, blood, bile salts, and ketones; volume
and specific gravity were also measured. A
second concentration test was performed on
these rats by collecting urine over the last
6 h of a 24h period of water deprivation.
Samples were examined for crystals, and the
volume and specific gravity measured. Urine
pH was measured on separately collected
fresh samples.
In Exp. 1, 4 rats from each group were
killed at 4, 26 and 52 weeks for interim patho-
logical examination. Animals that died during
the study were autopsied, unless this was
precluded by advanced autolysis or cannibal-
ism. Those found in extremis, or surviving to
102 weeks were killed by exsanguination
from the abdominal aorta under barbiturate
anaesthesia. The kidneys were weighed, and
fixed in 10% buffered formalin. The presence
of any macroscopic calculi in the urinary
tract wras noted. The bladders were gently
distended by injection offixative, opened and
examined for gross lesions. All other tissues
appearing abnormal at post mortem were
preserved in formalin. After fixation, the
bladders were cut transversely into 3 pieces.
The right kidney was cut transversely and the
left longitudinally. All tissues were embedded
in paraffin wax, sectioned and stained with
haematoxylin and eosin.
Statistical analyses. In Exp. 1, Group F
was compared with Groups A and G, and
Group A with Groups B, C, D and E. In Exp.
2, Groups H, I and J were compared with
each other. Cumulative mortality was ana-
lysed by the method of Peto & Pike (1973);
differences in body weights and urine analyses
were examined by Student's t test; food and
w-ater consumption were analysed by Fried-
man's test (1937) and by the Kruskal &
Wallis test (1952). Kidney weights and kidney
and bladder pathology -were compared by x2
or Fisher Exact Test.
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RESULTS
General observations, mortality and weight
gain
A proportion of rats ingesting either
OTS-free or OTS-contaminated saccharin
in the drinking water (Groups B and D)
developed a mild diarrhoea that persisted
throughout the study. Otherwise the be-
haviour and appearance of rats in all
groups in Exps 1 and 2 were normal.
Although in Exp. 1 there was a tendency
for rats in all groups treated with MNU
(A-E) to die earlier than rats not receiving
MNU (F and G) cumulative mortality was
significantly increased only in Groups B
and D, which were given saccharin in the
drinking water (Table II). In these 2
TABLE II.-Cumulative mortality
Total no. of deathls
Week,-
on
test A B
1
9
17
25
36
43
52
60
68
76
84
96
1
1
3
6
10
12
12
16
22
34
0
3
3
11
17
22
27
32
35
43
49
Exp. I
Group
C D
0
0
0
0
3
3
7
8
10
11
16
25
0
1
4
4
7
11
16
19
23
28
37
44
E F
0 0
0 0
1 0
2 0
3 1
4 2
5 2
6 2
7 5
11 8
16 13
28 24
G
0
0
0
0
1
1
2
2
5
12
22
1-
I2
3
Exp. 2
Group:
I I J
0 0
I 0
2 0
2 0
4 0
l 6 0
6 1
t 7 3
l1 5
; 17 6
22 11
; 27 20
Trend 23-34*** 14-46***
Figures are the total number of animals (lea(l or
killedj in extremis from groups of 51 (A-G) or 50
H-J).
Groups marked with asterisks differ significantly
from their appropriate controls (Peto & Pike, 1973).
***P < 0-001.
groups, only 2 and 7 rats respectively
were still alive at 96 weeks. No significant
differences in mortality were seen in
Groups H-J in Exp. 2.
Rats in Groups E and G weighed less
than their relevant controls at the start
of Exp. 1 and the differences had in-
creased by 9 weeks (Table III). By Week
25, the groups given saccharin in the
drinking water (B and D) had also sig-
nificantly smaller body-weight gains than
the relevant controls, and the reduced
body-weight gains in these 4 groups per-
sisted throughout the experiment. In
Exp. 2, no differences in body-weight were
seen between rats receiving OTS with or
without MNU, despite a slightly higher
initial body weight in Group J. Rats from
the saccharin-treated Group H tended to
have slightly higher body weights than
those in Groups I or J, but the differences
were only statistically significant inter-
mittently.
Food and water consumptions
In Exp. 1, food consumption showed no
consistent differences between the groups,
with some groups having occasionally
slightly higher or lower consumptions than
corresponding controls. However, when
the data were analysed on a cumulative
basis between 4, 13, 41 and 92 weeks
(Friedman, 1937) both the saccharin-
treated groups (B and D) and the high-
dose OTS group (E) showed reduced con-
sumption (Table IV).
In Exp. 2, occasional differences in food
consumptions were also seen between the
3 groups, the cumulative food consump-
tion being significantly higher in Group H.
Water consumption was decreased in
groups receiving saccharin (B and D) or
high-dose OTS (E and G) after 5 weeks of
treatment in Exp. 1 and, by 13 weeks, the
differences were statistically significant in
all 4 groups. Consumption remained low
in Groups E and G for the duration of the
experiment, but in Group B, water intake
had returned to control levels by 52 weeks,
whereas Group D had raised consumption
for the last year of the experiment. In
Exp. 2, the saccharin treated Group H had
a significantly higher cumulative water
intake than Groups I and J.
The calculated daily intakes of sac-
charin and OTS in all groups are given in
Tables I and V. The desired intake of
saccharin in Groups B, D and H was
2 g/kg/day. However, because of fluctua-
tions in food and water consumption,
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TABLE IlI.-Mean body weights
Body weight (g)
Exp. 1
133
Exp. 2
Week A___
on Group: Group:
test A B C D E F G H I J
0 189 189 188 188 183 189 181** 144 144 150*
1 233*** 232* 232 235* 233 240 224*** 187* 181 186
5 248*** 251 254 253 239* 261 242*** 218* 211 212
9 266* 267 272 271 250** 276 254*** 231 230 232
13 277* 268* 281 268* 261*** 287 261*** 248 243 243
17 283* 271* 289 278 269** 296 271*** 261 255 256
25 296** 271*** 304 276*** 277*** 312 279*** 278 270 273
39 323 276*** 324 278*** 296*** 332 300*** 303* 290 293
52 354 282*** 356 297*** 318*** 373 317*** 325* 311 310
68 364 293*** 371 301*** 329*** 391 330*** 352 335 356
85 356 273*** 373 275*** 326* 384 331*** 358 349 350
97 340 236* 355 305 319 362 332* 353 345 348
Figures are the mean for all survivors in each group. Those marked with asterisks differ significantly
from their appropriate controls (Student's t test).
*P<0.05; **P<0-01; *** P<O-OO1.
TABLE IV. Food and water consumption
Exp. 1
Group:
B C D
19-0 19 6
19.1 19 5
15 6 17 0
12.6* 143
16 2 17 6
16.5** 17 4
149 16-6
13 9 16-0
24 7 19 3
9.2** 18 2
30-1 365
27-6 34.4
26 1 38 9
15.8** 33.7
19 9 34.7
20.4* 32 6
32 6 29 9
33 6 33.7
29 6 38 9
258 369
Exp. 2
Group:
E F G H I J
Food consumption (g/rat/day)t
200 192 193
19 8 17-1 18 8
16 1 156 168
13.9** 14.7** 14 6
15 1 14-8 16-3
15.3* 16.5* 15 4
158 160 165
15-0 15-5 16 1
17-0 19-0 19.1
15.6* 17.6* 17 5
Water consumption (ml/rat/dat)lt
35 6 340 34 3
30 3 25 1 40 1
268 20.3* 378
17.4** 19.8* 366
214 17.1* 364
23.0** 20.8* 280
378 20.6** 30-9
37 9 232 31 8
516 24 1 31 7
530 353 37.5
18 9
17 7
15 7
14 7
14.9
15 9
16-0
14 4
21 6
17 5
36 6
24-2
22.1**
18.8*
16.9**
18.8**
19.1 *
19.2*
23 5
27.8*
16 8 17-1
17 4 17 5
18 1 18 4
18 7 17 2
16.9 159
19-0** 17 5
18 5 17 8
16 8 14 5
18 6 16 6
17.5* 16-4
33 6 35.9
33.4 34.9
39 6 38 2
35.5 37.5
35.4 37-7
40.7* 38 6
39.6* 31 5
45.8* 33.4
54 2 33 8
50.1* 39 1
16 6
16*3
18 8
16 8
15 4
17-0
18 5
15 2
16 3
16 3
30 8
28-0
33.5
32 8
32 1
30 3
30 8
30 6
32 4
28 8
Food and water consumption figures are means for 9 cages each containing initially 7 rats in Groups A-G
and for 10 cages each containing initially 5 rats, in Groups H-J. Those marked with asterisks differ sig-
nificantly from their appropriate controls.
t Friedman's test.
I Kruskal and Wallis test.
* P<0-05; ** P<O-O1.
Week c-
on
test A
0 17 8
4 198
9 17 8
13 14 5
24 17 7
41 18 5
52 16 7
68 17-0
84 22 0
92 17 6
0 27-4
5 34.9
9 34-2
13 34-0
24 25 3
41 30 3
52 30 8
68 31 7
84 33 2
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TABLE V.-Calculated intake of OTS and saccharin
Compound intake (g/kg/day)
Week
on
test A
0 0
1 0
4 0
9 0
13 0
16 0
24 0
41 0
52 0
68 0
84 0
92 0
Exp. 1
B
0
3-20
2-93
0-98
1-28
2-27
2-11
2-06
3-31
3-26
3.15
3-13
C
0
0.07*
0 07
0-10
0 07
0 07
0-06
0-06
0-19
0-20
0-24
0-22
Group:
D
0
3-56
2-71
0 99
1 40
2-43
2-20
2-74
3-62
3-58
5-28
5-17
E
0
0-08
0-08
0-08
0-08
0-06
0 06
0 07
0 07
007
0-08
0-12
F
0
0
0
0
0
0
0
0
0
0
0
0
Week
on
G test
0 )
0-10 1
0-13 5
009 9
007 13
009 16
0-06 25
0-06 42
0-06 51
0-06 68
0 07 85
0-08 98
H
0
1-80
1-58
1-56
1-51
1-76
1-53
1*95
1-82
1-67
1-81
1-70
Exp. 2
Group:
I
0-10
0-08
0-08
0 07
0-08
0-07
0 09
0-08
0 07
0-08
0-08
J
0
009
0-08
0-08
0 07
0 09
0 07
0-08
0 09
0-07
0-08
0-08
* Compound intake in Group Cexpressedl as mg/kg/day.
The values for compound intake are calculated from data on water consumption a wid bo(ly weight in Exp. 1
and from data on food consumption and body weight in Exp. 2.
Groups B and D received rather less than
this amount for the first 4 months of the
study, and more during the last 12 months.
Group H received slightly less than the
desired intake throughout the study.
Urine studies and kidney weights
In Exps 1 and 2, some rats from all
groups pretreated with MNU (A-E and I)
had erythrocytes, acute inflammatory
cells and cell debris in the urine when
examined 2 weeks after MNU treatment.
Intermittent haematuria was found in
these groups throughout the experiments.
Semi-quantitative tests for glucose,
ketones, bile salts and albumin showed no
marked differences between any groups.
Crystalluria was observed in all groups,
becoming more apparent after the first 6
months of treatment. The range of pH
measured on fresh urine from individual
rats varied from 5-8. With time, there was
a tendency for more samples to have an
ncid pH, but this occurred in all groups
and could not be related to treatment.
Measurements of cell excretion were simi-
lar in all groups (Table VI).
In Exp. 1, concentration/dilution tests
performed during the first 12 months
showed higher urinary specific gravity and
smaller volume from rats in Groups B, D,
E and G than in appropriate controls
(Table VI). In the concentration tests, the
most statistically significant difference
was observed in these 4 groups when
specific gravities were compared on the
0-6h sample. In the dilution test, Groups
B and D consistently showed highly sig-
nificant differences ofboth urinary specific
gravity and volume, whereas similar
changes in Groups E and G were only
statistically significant intermittently. The
pattern of changes seen in the dilution
test persisted throughout the experiment
but, in the concentration test, the differ-
ences became less marked with time.
At 50 weeks, a further observation was
recorded in Groups B and D, when de-
creased specific gravities occurred in the
18-24h sample. Similar findings were
observed for the remainder of the experi-
ment, but the decreases were not always
statistically significant.
In Exp. 2, concentration tests indicated
a significant decrease in specific gravity of
urine from rats pretreated with MNU
(Group I) when 18-24h samples were
analysed at 2, 7 and 11 weeks. Concentra-
tion tests performed during the rest of the
experiment, and dilution tests throughout
the experiment, showed no consistent
differences between the groups.
Absolute kidney weights were lower in
Groups B, D and G than in the relevant
controls (Table VIII). Expressed relative
to body weight, Groups B, D, E and G had
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TABLE VI.-Renal concentration and dilution tests and urinary cell excretion rates
Cell
excretion
Grouip (103/h)
A
B
C
D
E
F
G
A
B
C
D
E
F
G
A
B
C
D
E
F
G
A
B
C
D
E
F
G
H
I
J
H
I
J
H
I
J
H
I
J
7
1
2
1
3
3
1
°1 2
0
1
1
1
1
3
1
2
3 1
1
0
3
1
2
3
3
1
1
1
1
Concentration test Dilution test
A (2h)
Sp. gr. Volume (ml) A
, - A Volume
0-6 h 18-24 h 0-6 h 18-24 h Sp. gr. (ml)
Exp. 1
Week 13
1-038 1-068 1-3 0 7 1-005 3*5
1-082*** 1-077 04 0 7 1-038* 1.1*
1-037 1-049 2-1 1-5 1-007 4*0
1-070*** 1-072 0*9 0 9 1-016* 2-4
1-060*** 1-069 1-0 0-8 1-012* 2-7
1-029 1-073 1.1 0-4 1-005 4-5
1-060** 1-065 0-8 0*9 1-008 2-6
Week 25
1-035 1-072 2-4 0-6 1.010 3-6
1-071*** 1-070 1-0* 0-6 1-071*** 0.3**
1-033 1-055 2-9 1-3 1-006 3-9
1-075*** 1-071 1-7 1.1 1-056** 1*1
1-059** 1-073 1-2 0-7 1-014 2-2
1-033 1-081 1-3 0 4 1-003 5-2
1-071 1-086 0*9 0-2* 1-019* 2-4***
Week 36
1-039 1-075 1-6* 0-6 1-005 5-8
1-064*** 1-068 2-0 0 7 1-045*** 0.7***
1-039 1-066 2-3 0-8 1-004 6-1
1-067** 1-064 2-0 0 9 1-052*** 0-6***
1-066** 1-070 0.9* 0 5 1-013* 2-8*
1-044 1-076 2-5 0 5 1-005 5-6
1-066*** 1-086 1-3* 0-8* 1-011 3-1*
Week 55
1-044 1-079 1-3 0-6 1-004 5-4
1-063* 1-060* 1-8 0 7 1-046*** 1.1***
1-035 1-074 2-0 0-6 1-005 5 9
1-055 1-046*** 2-8* 1-2 1-041** 0-8***
1-066* 1-080 1 1 0-6 1-009* 2-9*
1-040 1-082 2-1 0 5 1-004 6-6
1-073*** 1-093 0-8*** 0 7 1-008* 1-8***
Exp. 2
Week 2
1-041 1-074 2-3 0 7 1-007 2-7
1-026 1.059*** 1-2 0-8 1-006 2-1
1-031 1*073 1-3 0-6 1-006 2-8
Week 11
1-051 1-084 1-3 0 7 1-009 3.3
1-042 1-067** 1-5 0-6 1-010 3-1
1-038 1-072 2-1 0-6 1-006 4-1
Week 37
1-051 1-076 1*6 0 7 1-006 4.9
1-054 1-073 1-2 0-6 1-007 4-1
1-035 1-065 1-7 0-6 1-004 5-3
1-033
1-037
1-037
Week 75
1-063 3-4
1-066 2-7
1-079 2-9
1-3
1-1
0 9
1-006
1-004
1-004
5-4
6-8
6-4
The figures are means for groups of 7 (A-G) or 10 (H-J) rats. Those marked with asterisks differ significantly
from their appropriate controls. (Student's t test). *P<0.05; **P<0-01; ***P< 0-001.
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TABLE VII.-Incidence of neoplasia in tissues other than kidney and bladder
Tissue
Adrenal
Pheochromocytoma
Brain
Glioma
Gastro-intestinal tract
(a) Stomach
Carcinoma
Leiomyosarcoma
(b) Ileum
Adenocarcinoma
Histiocytoma
Reticulum cell sarcoma
Liver
Cholangioma
Hepatocellular carcinoma
Reticulum cell sarcoma
Kupffer cell sarcoma
Lung
Adenoma
Metastasis (from liver)
Lymph nodes
Lymphosarcoma
Haemangioma
Angiosarcoma
Mammary gland
Adenoma
Fibroadenoma
Adenocarcinoma
Ovary
Granulosa-cell tumour
Pancreas
Islet-cell adenoma
Peritoneum
Angiosarcoma
Pituitary
Adenoma
Skin & s.c. tissue
Lipoma
Fibroma
Neurofibroma
Sarcoma
Fibrosarcoma
Lymphosarcoma
Basal-cell carcinoma
Squamous-cell carcinoma
Spleen
Myeloid leukaemia
Thymus
Lymphosarcoma
Thyroid
Adenoma
Adenocarcinoma
C-cell carcinoma
Uterus
Polyp
Fibroma
Adenocarcinoma
Sarcoma
Leiomyosarcoma
Pericytoma
Haemangiosarcoma
Reticulum-cell sarcoma
Exp. 1
A B C D E F G
2
1
1
1
1
I
. * . . 1 1
I
* * * . * . 1
1
I
1
3
2
1
1
4
1
1
1
1
2
1
2
1
3
1
2 1
1
1
28 8 24 8 28 36 29
1
1
1
2
2
1
2
I
1 1
2 2 2 2 1 1
* 1 * *
1 2 1 3 2
2
1
1 1
* . .
.
1
I1
136
Exp. 2
-A -"
H I J
1 .
1
1
1
1
1 1
1
2
4
1
1
4
1
I
32 25 32
* .
1 I
.
1 1
1
I
3 1 7
1
1
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TABLE VIII.-Terminal kidney weights and kidney pathology
Exp. 1
A B C D E
Feature 48
Weights
Absolute weight (g) 2-59
Relative weight (g/kg bw) 0-85
Pathology
Glomerulonephrosis 35
Pyelonephritis 4
Hydronephrosis 4
Pelvic epithelial
hyperplasia 13
Mineral deposits:
Macroscopic calculi 1
Cortico-medullary 1
Other 4
Neoplasia:
Transitional cell
carcinoma 0
Adenocarcinoma 0
Undifferentiated
carcinoma 0
Angioma 0
Hamartoma 1.
F
No. ofrats examined:
49 48 44 47 50
2-32* 2-51 2-21** 2-58 2-49
0-98* 0-78 0-96* 0.94* 0 75
34 40 27 41
1 4 5 1
0 4 3 1
49
0
2
Exp. 2
G H I J
No. of rats examined:
48 50 49 50
2-41*
0-80
48
0
0
2-64 2-43 2-30
0-86 0-82 0-72
45
0
3
36
6
10
43
1
1
24* 16 29*** 13 0 0 43*** 19 21
1 3 1
7 0 4
14*** 11 19***
0
0
9
0
0
4
0
0
7
3
8
44***
4
6
19
1
8
24
1 1 1 3 0 0 0 2 0
1 0 0 0 0 0 0 0 0
0
0
0
0
0
0
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
0
0
The figures represent the incidence of findings amongst the number of rats shown. Those marked with
asterisks differ significantly (X2 or Fisher's Exact Test) from their appropriate controls.
*P<0.05; **P<0-01; *** P 0-001.
increased kidney weights. In Exp. 2, the
saccharin-treated Group H showed the
highest absolute and relative kidney
weights and Group J the lowest.
Pathology
A wide variety of non-neoplastic and
neoplastic pathology was seen in all groups
in both experiments. The changes were
similar to those reported in ageing rats,
and no treatment-related pathology could
be determined in organs other than kidney
and bladder. Tumours arising away from
the urinary tract are summarized in
Table VII. The relatively small number of
pituitary tumours in Groups B and D
was consistent with the early mortality in
these groups.
Kidney pathology. Glomerulonephrotic
changes, consistent with ageing, were seen
in all groups (Table VIII); the lower inci-
dence ofsevere glomerulonephrosis seen in
Groups B and D again reflected the early.
mortality in the MNU and saccharin-
treated rats. Pyelonephritis occurred in
some rats from all groups pretreated with
MNU (A-E and I).
In Exp. 1, only MNU-pretreated groups
showed hyperplasia of the pelvic epi-
thelium (Fig. 1) the incidence being sig-
nificantly higher after administration of
saccharin (Groups B and D). Microscopic
calcium deposits were present in some rats
from all groups (A-G) but again with a
significantly higher incidence in Groups B
and D. Calcification occurred in the col-
lecting ducts, the pelvic epithelium, and
the pelvic space, as well as in the area of
the cortico-medullary junction. The few
macroscopic calculi recorded were asso-
ciated with MNU treatment.
In Exp. 2, 40% ofrats in both Groups I
and J and 80% ofrats fed saccharin alone
(Group H) developed pelvic epithelial
hyperplasia. Microscopic calcification was
observed in all 3 groups, but again the
highest frequency (90%) was in Group H.
Macroscopic calculi occurred infrequently
in all groups.
Small numbers of kidney neoplasms,
137J. HOOSON, R. M. HICKS, P. GRASSO AND J. CHOWANIEC
FIG. 1. Alarke(l hyperplasia of renal pelvic epithelium in the kidney of an AINU-pretreated rat given
OTS for 12 week;s (Grotup E). Inflammatory-cell debris (1)) is present in the pelx-ic space (PS).
HPE = hypeiplastic pelvic epithelium. H & E, x 100.
mostly transitional cell carcinomas, were
found to be associated with MNU treat-
ment but, in addition, one undifferentiated
carcinoma was also seen in Group J.
Bladderpathology. Hyperplasticlesions
ofthe bladder were classified as mild focal,
mild diffuse, irregular or papillary. Mild
hyperplasias were characterized by an
increased number of epithelial cell layers,
which remained regular and well differ-
entiated (Fig. 2). If more than 20% of the
epithelium was hyperplastic, the lesion
was termed diffuse. Irregular hyperplasias
were basically endophytic in growth
pattern, and were characterized by broad-
front extensions into the lamina propria,
including Von Brunn's nests (Figs 3 and 4).
Papillary hyperplasias were exophytic
lesions, consisting of fingerlike projections
into the bladder lumen of well differenti-
ated transitional epithelium, surrounding
a thin fibro-vascular stroma (Fig. 5).
Neoplasms were diagnosed as malignant
on the basis of loss of differentiation,
cellular atypia, nuclear pleomorphism,
number of mitoses and invasion. Inevit-
ably, these judgements were subjective in
certain cases, and consequently some
exophytic neoplasms were diagnosed as
benign papillomas by 2 authors (JH; PG)
and as papillary carcinoma in situ (PIS,
WHO classification, 1973) by 2 authors
(RMH; JC) (Figs 6a,b).
The bladder lesions observed at interim
kills at 1, 6 and 12 months in Exp. 1 are
shown in Table IX. One unequivocal
neoplasm was seen at, 12 months in
Group D.
Terminal bladder pathology for all
groups is illustrated in Table X. In Exp. 1,
about 3000 of rats in groups pretreated
with MNU showed some degree of mild
hyperplasia of the bladder epithelium. A
smaller number of rats in these groups
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FiG. 2. Mild diffuse hyperplasia of bladder epithelium from an MNU-pretreated rat given OTS-free
saccharin for 50 weeks (Group B). H & E, x 160.
~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~
. 11 l | l * .2'--.H a~~~~~~~
FIo#. 3.-Irregularhyperplasia [P1 carcinoma-RMH; JC] ofbladderepitheliumfromanMNU-pretreated
rat given OTS-contaminated saccharin for 4 weeks (Group D; interim kill). H & E, x 160.
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FiG. 4.-Irregular hyperplasia [Pl carcinoma-RMH; JC] of bladder epithelium from an MNU-
pretreated rat given OTS-free saccharin for 40 weeks (Group B). Squamous metaplasia can be seen
in one area. H & E, x 160.
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Fma. 5.-Papillary hyperplasia [P1 carcinoma-RMH; JC] of bladder epithelium from an MNU-
pretreated rat given OTS for 12 weeks (Group E). Mitotic figure arrowed. H & E, x 160.
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FIG. 6. (a) Papilloma [papillary carcinoma in situ-RMH; JC] of bladder epithelium from an MNU
pretreated rat given OTS-free saccharin for 50 weeks (Group B). H & E, x 63. (b) Highermagnifica-
tion of 6 (a) to show arrangement ofepithelial cells. H & E, x 160.
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FIG. 7.-Transitional-cell carcinoma of the bladder from an MNU-pretreated rat given OTS-
contaminated saccharin for 63 weeks (Group D). H & E, x 160.
FIG. 8. Transitional-cell carcinoma of the bladder with invasion of underlying muscle, from an
MNU-pretreated rat given OTS for 99 weeks. L =bladder lumen; E =hyperplastic epithelium; C =
transitional-cell carcinoma; * =nests ofcarcinoma cells in lamina propria and muscle. H & E, x 63.
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Finding
Mild focal hyp.
Mild diffuse hyp.
Irregular hyp.*
Papillary hyp.*
Mild focal hyp.
Mild diffuse hyp.
Irregular hyp.*
Papillary hyp.*
Mild focal hyp.
Mild diffuse hyp.
Irregular hyp.*
Papillary hyp.*
Proliferation of spindle cells
in lamina propria
Transitional-cell carcinoma
* 9/9 lesions elassified as
authors.
hyp = hyperplasia.
Experimental group
A B C D E F G
No. of rats examined
at each time:
4 4 4 4 4 4 4
4 weeks
6 months
2 . 2 . 2 .
1 .12.
1 .
12 months
I . 2
.I.
Pi carcinomas by 2
developedmoresevereproliferative lesions,
the incidence of these lesions being signifi-
cantly higher in groups given saccharin
(B and D). Although 2 authors classified
these proliferative changes as irregular or
papillary hyperplasias, the other 2 authors
diagnosed 15/19 cases as carcinomas,
Stages PIS, Pla, or Plb (WHO classifica-
tion, 1973).
Unequivocal bladder carcinomas were
found in all groups pretreated with MNU
(Fig. 7) and a small number ofconnective-
tissue neoplasms occurred in the same
groups. Invasion of the bladder muscu-
lature was seen in only 6 instances (Fig. 8)
and metastases to other organs were
never seen. The incidence ofneoplasia was
not significantly different in any of the
groups pretreated with MNU, irrespective
ofthe type ofclassification used. However,
neoplasms were first detected in the
saccharin-treated groups (B and D) and
the mean latent period was also shorter in
these groups (Table XI).
TABLE X.-Terminal bladder pathology
Exp. 1
A B C D E F
Finding
Macroscopic calculus
Necrosis and epithelial calcification
Necrosis and inflammatory cell infiltration
Foci oflymphocytes in lamina propria
Spindle-cell proliferation in lamina propria
Hyperplasia:
Mild focal
Mild diffuse
Irregular*
Papillary*
Neoplasia:
Transitional-cell papillomat
Transitional-cell ca.
Transitional-cell ca. with muscle invasion
Squamous-cell ca. with musele invasion
Leiomyosarcoma
Mesothelioma
Fibroma
Angioma
Angiosarcoma
No. of rats examined:
48 49 48 44 47 50
11
4
2
5
6
2
14
4
5
7
5
2
4
1
1
2
5
8
1
4
7
1
1
2
1
2
5
12
5
.3
5
3
2
1
5
Exp. 2
G H I J
No. of rats
examined
48 49 49 50
8
1
1
2
10
5
2
2
7
10
1
2
3
14
3
2
* 15/19 (Exp. 1) and 5/5 (Exp. 2) lesions classified as Pi carcinomas by 2 authors.
t Classified as papillary carcinoma in situ by 2 authors.
The figures represent absolute numbers.
10
TABLE IX.-Interim bladderpathology
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TABLE XI.-Summary ofproliferative lesions in the bladder
Mild
No. epithelial
of rats hyperplasia
examined (%)
Marked
epithelial
hyperplasia
(%~)
Epithelial
neoplasms
(O%)
[carcinomas]
-RMH;JCI
4 25
[29]
10 25
[33]
4 27
[31]
18* 25
[36]
4 19
[23]
9 37
[43]
* Differ significantly from corresponding control (Fisher's Exact Test P < 0-05).
Bladder calculi were infrequent or
absent in all groups pretreated with MNU.
Untreated controls (F) and rats given
OTS alone (G) showed no bladder path-
ology.
In Exp. 2, pretreatment with MNU
(Group I) elicited similar pathological
changes to those already described, but
more animals were affected (Table X).
Treatment with saccharin or OTS alone
(Group H and J respectively) elicited mild
hyperplasia in 2% of rats, but marked
hyperplastic changes, neoplasia and cal-
culi were absent.
The proliferative changes in the bladder
obtained in both experiments are sum-
marized in Table XI.
DISCUSSION
Previous work has shown that pro-
longed administration of saccharin, in the
diet or drinking water, to rats pretreated
with a non-carcinogenic dose of MNU
(Hicks et al., 1973a, 1975) or a threshold
dose of FANFT (Cohen et al., 1979) pro-
duced a high incidence of tumours of the
urinary bladder.
In the present experiments, it had been
intended to use a non-carcinogenic dose
of MNU also, but in practice the dose
administered, although the same as had
been used in earlier studies (Hicks et al.,
1975) produced bladder neoplasms in 27%
of rats in Exp. 1, and 38% in Exp. 2.
Hyperplastic lesions of the bladder were
found in a further third ofthe rats in each
experiment and pathological changes in
the kidney, including a small number of
neoplasms, were also found after MNU
pretreatment. The problem of the varying
carcinogenic potency of different batches
of MNU has been discussed elsewhere
(Hicks et al., 1978) and similar difficulties
have been encountered in studies with
FANFT (Jacobs et al., 1977; Cohen et al.,
1979). Consequently, in the present ex-
periments the promoting activity of
saccharin and OTS was evaluated against
a background of pre-existing pathology
and, under these conditions, both OTS-
contaminated saccharin and OTS-free
saccharin failed to increase the number of
unequivocal bladder carcinomas. Neo-
plasms may, however, have occurred
earlier in saccharin-treated groups; among
the interim kills, the only unequivocal
bladder carcinoma was found in a sac-
Group
Exp. 1
A 48
B 49
C 48
D 44
E 47
31
37
27
39
32
F 50
G 48
Connective
tissue
ne3plasms
(0)
4
4
0
5
2
4
Exp. 2
H
I
J
Rats with
neoplasms
27
[31]
29
[37]
27
[31]
25
[36]
21
[26]
38
[45]
AMean
latent
period
(Week)
87
55
76
52
95
71
49
49
50
2
23
2
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charin-treated rat, implying an earlier
development of neoplasia; carcinomas
were also seen earlier in other rats from
these groups, as a consequence of pre-
mature mortality. However, mortality
may have been associated with the severe
kidney pathology present in these animals
and therefore it is not possible to say with
certainty that the time to tumour de-
velopment was shortened.
Administration of both saccharins did
increase the number of hyperplasias, in-
cluding severe hyperplasias, ofthe bladder
epithelium, seen after MNU pretreatment,
the finding being significant with OTS-
contaminated saccharin. Despite differing
interpretations by the authors of the
classification of certain of these prolifera-
tive lesions, the conclusion was unanimous
that they occurred more frequently in the
saccharin-treated animals than in those
receiving MNU alone.
The variable interpretation of certain
bladder lesions reflects the absence of a
generally agreed system of classification
for rat bladder neoplasia, the problem of
assessing invasion of the underlying con-
nective tissue, and our incomplete know-
ledge ofthe behaviour ofsuch proliferative
lesions in the rat bladder. There is no
doubt that bladder neoplasia induced by
a variety of carcinogens is often preceded
by hyperplastic lesions that are papillary
or nodular in growth pattern (Tiltman &
Friedell, 1971; Kunze et al., 1976) but it is
possible that some such lesions are not
progressive, or even reversible, and that
the reversible and irreversible hyper-
plasias induced by carcinogens cannot be
distinguished histologically. Moreover,
similar proliferative lesions have been
found in regenerating epithelium not asso-
ciated with neoplasia (Shirai et al., 1977).
However, the marked proliferative lesions
seen in the present experiments have been
regarded by some (Hicks & Chowaniec,
1978) as irreversible conditions, which in
many cases show signs of early stromal
invasion (Pla or b carcinomas). If this is
correct, then preneoplasia develops very
early; these lesions were identified in
moribund rats killed at 1 and 6 weeks
after MNU treatment and in 4-week
interim kills. Further experimental work
is required in this area before such prob-
lems can be resolved.
The failure of saccharin to increase the
number of bladder neoplasms after treat-
ment with a carcinogenic dose of MNU is
in keeping with the recent results of Mohr
et al. (1978) who showed that if the initi-
ating agent was used at a dose that itself
produced neoplasia, no promoting effect of
saccharin could be demonstrated. These
workers observed that daily ingestion of
2% saccharin did not alter the incidence
of bladder carcinoma in groups pretreated
with a dose of MNU that produced neo-
plasia in 40%o of rats. Our findings, and
those of Mohr et al. (1978) are analagous
to the early work on 2-stage carcino-
genesis in mouse skin (Berenblum, 1941).
In these experiments, it was found that
the tumour incidence after a carcinogenic
dose of benzpyrene could not be increased
by subsequent application of croton oil,
and Berenblum concluded that, in order
to demonstrate 2-stage carcinogenesis, the
initiating agent must be used at a
threshold, or subcarcinogenic dose.
The current experiments were designed
to elucidate the role of the saccharin con-
taminant OTS in the production ofbladder
cancer. Apart from the consequences
arising from a reduced water intake (i.e.
reduced body weight, food intake and
concentrated urine) addition ofOTS to the
drinking water did not alter the incidence
of toxicological or pathological changes
induced by MNU alone; the higher inci-
dence of bladder neoplasia observed in
rats pretreated with MNU and given OTS
in the diet (Exp. 2) was not significant; a
different batch of MNU was used in this
experiment, with a greater carcinogenic
potential than the batch used in Exp. 1
(Hicks et al., 1-978). Administration of
OTS alone, in the diet or drinking water
did not produce either bladder hyper-
plasia or neoplasia. These results are in
contrast to the findings of Schmahl (1978)
who reported that 5/76 rats fed 200 mg/kg/
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day OTS and 3/75 rats given 20 mg/kg/
day, developed bladder neoplasia. How-
ever, in a 2-generation study by Arnold
et al. (1977a) dietary administration of
OTS at levels of 2-5, 25 or 250 mg/kg/day
did not induce an increase in bladder
neoplasia in either the Fo or the F,
generation.
OTS is a sulphonamide, and has been
shown to inhibit carbonic anhydrase in
vitro (Kinzer, 1973). Similar enzyme in-
hibition in vivo could favour the formation
of urinary calculi by increasing urinary
pH, and it has been suggested that
urolithiasis may have been a factor in the
previously reported neoplastic response of
the rat bladder to saccharin.
In our experiments, no consistent
changes in urinary pH or crystalluria
were observed in any of the treatment
groups, and only a very small number of
rats developed bladder calculi. In Exp. 1,
4 groups of rats, as a result of reduced
water intakes, produced concentrated
urines for most of the experimental
period. Although increased crystalluria
and calculus formation might have de-
veloped under such conditions, in practice
they did not. Furthermore, bladders from
rats producing concentrated urine Groups
E and G) were histologically similar to
bladders from control groups (A and F),
which secreted urine of normal specific
gravity. Thus the heightened proliferative
response in the bladders of rats given
saccharin in the drinking water (B and D)
could not be attributed to the concen-
trated urine secreted by rats in these
groups. Collectively, these observations
lend no support to the hypothesis that
increased urinary concentration, crystal-
luria or urolithiasis play an important role
in the development of bladder neoplasia
after saccharin administration.
However, in contrast to the situation in
the bladder, the increased kidney pelvic
epithelialhyperplasia, seen in groupsgiven
saccharin alone, or given saccharin after
MNU pretreatment, was accompanied by
an increased incidence of mineralization
in the kidney. Similar findings have been
reported previously in rats treated with
contaminated saccharin alone (Chowaniec
& Hicks. 1979). The results of the current
experiments using OTS-free saccharin
confirm that the increased kidney hyper-
plasia and mineralization in saccharin-
treated rats with or without MNU ad-
ministration was associated with saccharin
per -se, and not with the presence ofOTS.
The mechanism of saccharin carcino-
genicity in the rat bladder is not yet
understood. However from the results of
the work reported here, there is no
evidence that OTS contamination plays a
causative role in saccharin-induced path-
ology. This conclusion supports the find-
ings of Cohen et al. (1.979) who used OTS-
free saccharin to promote bladder carcino-
genesis after treatment with a threshold
dose ofFANFT.
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